Hepatocellular Carcinoma Surveillance: A National Survey of Current Practices in the USA

Digestive Diseases and Sciences

Volumn 59, Issue 12, 2014, Pages 3073-3077

  Joshi, Kartik ^a   Mendler, Michel ^a   Gish, Robert ^b   Loomba, Rohit ^a   Kuo, Alexander ^a   Patton, Heather ^a   Kono, Yuko ^a  

^a UCSD MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Hepatocellular carcinoma; National survey; Surveillance; Ultrasound

Indexed keywords

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; FEMALE; GASTROENTEROLOGIST; GASTROENTEROLOGY; HEALTH CARE SURVEY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PHYSICIAN ASSISTANT; PRACTICE GUIDELINE; PRIVATE PRACTICE; CARCINOMA, HEPATOCELLULAR; ECHOGRAPHY; EPIDEMIOLOGY; HEALTH SURVEY; INCIDENCE; INFORMATION PROCESSING; LIVER; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; DATA COLLECTION; HUMANS; INCIDENCE; LIVER; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; UNITED STATES;

EID: 84912561573     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3256-6     Document Type: Article

References (23)

1. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology. 2012;55:476–482.
2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–1127.
3. Chalasani N, Said A, Ness R, Hoen H, Lumeng L. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol. 1999;94:2224–2229.
4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236.
5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–943.
6. Benson AB 3rd, Abrams TA, Ben-Josef E, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7:350–391.
7. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
8. Davila JA, Morgan RO, Richardson PA, et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010;52:132–141.
9. Singal AG, Yopp A, C SS et al. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Int Med 2012.
10. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417–422.
11. Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008;6:1418–1424.
12. Pocha C, Dieperink E, McMaken KA, et al. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography—a randomised study. Aliment Pharmacol Ther. 2013;38:303–312.
13. Kim CK, Lim JH, Lee WJ. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med. 2001;20:99–104.
14. Yu NC, Chaudhari V, Raman SS, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:161–167.
15. Chalasani N, Horlander JC Sr, Said A, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol. 1999;94:2988–2993.
16. Singal AG, Nehra M, Adams-Huet B, et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: Where did surveillance fail? Am J Gastroenterol. 2013;108:425–432.
17. Singal A, Volk ML, Waljee A, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47.
18. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS data brief 2012:1–8.
19. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11:e1001624.
20. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–1491.
21. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27–S34.
22. Saab S, Nguyen S, Ibrahim A, Vierling JM, Tong MJ. Management of patients with cirrhosis in Southern California: results of a practitioner survey. J Clin Gastroenterol. 2006;40:156–161.
23. Khalili M, Guy J, Yu A, et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011;56:1516–1523.